Improvement of the Sepsis Survival Rate by Adenosine 2a Receptor Antagonists Depends on Immune Regulatory Functions of Regulatory T-cells

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Sep 23

PMID 36148230

Authors

Teng Zhang

Jie Zhao

Jingnan Fu

Guibing Chen

Tao Ma

Affiliations

Soon will be listed here.

Abstract

Adenosine shows a significant immunosuppressive effect in sepsis binding to the adenosine 2a receptor (A2aR). Both genetic deletion and pharmacological inhibition of the A2aR may improve survival in sepsis. However, available research on this protective mechanism is quite limited. We used an A2aR antagonist (ZM241385) to treat a cecal ligation and puncture model of normal mice or regulatory T-cell (Treg)-depletion mice and found that the protective effect of ZM241385 is dependent on Tregs. Mechanically, A2aR inactivation was associated with decreased frequencies and reduced function of Foxp3 Tregs, as evidenced by Foxp3 and CTLA-4 expression and classical effector T-cell proliferative assays, suggesting Treg modulation is a potential protective mechanism against sepsis. Simultaneously, the function and quantity of abdominal neutrophils were improved with ZM241385 treatment. To see if a link exists between them, Tregs and neutrophils were co-cultured, and it was found that ZM241385 blocked the inhibitory effect of Tregs on neutrophils. According to our research, Tregs play a key role in how A2aR antagonists improve sepsis prognosis and bacterial clearance.

Citing Articles

Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway.

Poblano-Perez L, Monroy-Garcia A, Fragoso-Gonzalez G, Mora-Garcia M, Castell-Rodriguez A, Mayani H Int J Mol Sci. 2024; 25(17).

PMID: 39273524 PMC: 11395442. DOI: 10.3390/ijms25179578.

suppresses the pentose phosphate pathway in human neutrophils via the adenosine receptor A2aR to enhance intracellular survival.

Vozza E, Daly C, ORourke S, Fitzgerald H, Dunne A, McLoughlin R mBio. 2023; 15(1):e0257123.

PMID: 38108639 PMC: 10790693. DOI: 10.1128/mbio.02571-23.

References

Pacheco Y, Lim C, Weichhart T, Valeyre D, Bentaher A, Calender A . Sarcoidosis and the mTOR, Rac1, and Autophagy Triad. Trends Immunol. 2020; 41(4):286-299. DOI: 10.1016/j.it.2020.01.007. View

Canavan J, Afzali B, Scotta C, Fazekasova H, Edozie F, Macdonald T . A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. Blood. 2012; 119(8):e57-66. PMC: 3816350. DOI: 10.1182/blood-2011-09-380048. View

Gomez G, Sitkovsky M . Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood. 2003; 102(13):4472-8. DOI: 10.1182/blood-2002-11-3624. View

Presneill J, Harris T, Stewart A, Cade J, Wilson J . A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med. 2002; 166(2):138-43. DOI: 10.1164/rccm.2009005. View

Mukhatayev Z, Ostapchuk Y, Fang D, Le Poole I . Engineered antigen-specific regulatory T cells for autoimmune skin conditions. Autoimmun Rev. 2021; 20(3):102761. PMC: 9285649. DOI: 10.1016/j.autrev.2021.102761. View

Venet F, Monneret G . Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2017; 14(2):121-137. DOI: 10.1038/nrneph.2017.165. View

Hotchkiss R, Coopersmith C, McDunn J, Ferguson T . The sepsis seesaw: tilting toward immunosuppression. Nat Med. 2009; 15(5):496-7. PMC: 3786779. DOI: 10.1038/nm0509-496. View

Teh C, Preston S, Robbins A, Stutz M, Cooney J, Clark M . Caspase-8 has dual roles in regulatory T cell homeostasis balancing immunity to infection and collateral inflammatory damage. Sci Immunol. 2022; 7(69):eabn8041. DOI: 10.1126/sciimmunol.abn8041. View

Chousterman B, Swirski F, Weber G . Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017; 39(5):517-528. DOI: 10.1007/s00281-017-0639-8. View

10.

Feunou P, Poulin L, Habran C, Le Moine A, Goldman M, Braun M . CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance. J Immunol. 2003; 171(7):3475-84. DOI: 10.4049/jimmunol.171.7.3475. View

11.

Burn G, Foti A, Marsman G, Patel D, Zychlinsky A . The Neutrophil. Immunity. 2021; 54(7):1377-1391. DOI: 10.1016/j.immuni.2021.06.006. View

12.

Margraf A, Lowell C, Zarbock A . Neutrophils in acute inflammation: current concepts and translational implications. Blood. 2021; 139(14):2130-2144. PMC: 9728535. DOI: 10.1182/blood.2021012295. View

13.

Bauza G, Moitra R, Remick D . Adenosine receptor antagonists effect on plasma-enhanced killing. Shock. 2013; 41(1):62-6. PMC: 3896973. DOI: 10.1097/SHK.0000000000000055. View

14.

Fredholm B, IJzerman A, Jacobson K, Klotz K, Linden J . International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001; 53(4):527-52. PMC: 9389454. View

15.

Scumpia P, Delano M, Kelly K, OMalley K, Efron P, McAuliffe P . Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol. 2006; 177(11):7943-9. DOI: 10.4049/jimmunol.177.11.7943. View

16.

Hou T, Qureshi O, Wang C, Baker J, Young S, Walker L . A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells. J Immunol. 2015; 194(5):2148-59. PMC: 4522736. DOI: 10.4049/jimmunol.1401876. View

17.

Oro J, Kimball A . Synthesis of purines under possible primitive earth conditions. I. Adenine from hydrogen cyanide. Arch Biochem Biophys. 1961; 94:217-27. DOI: 10.1016/0003-9861(61)90033-9. View

18.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

19.

Venet F, Chung C, Kherouf H, Geeraert A, Malcus C, Poitevin F . Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 2008; 35(4):678-86. PMC: 2789433. DOI: 10.1007/s00134-008-1337-8. View

20.

Piliponsky A, Shubin N, Lahiri A, Truong P, Clauson M, Niino K . Basophil-derived tumor necrosis factor can enhance survival in a sepsis model in mice. Nat Immunol. 2019; 20(2):129-140. PMC: 6352314. DOI: 10.1038/s41590-018-0288-7. View